Dr. Liu is a Research Fellow at St. George’s University of London. Since 2007, he has collaborated with Professor Angus Dalgleish investigating the role of immune modulatory drugs as anticancer agents.
Dr. Liu’s work focuses on developing novel approaches against cancer. These involve modifications to drug regimens as a way of enhancing activity of chemotherapy. Dr Liu’s research has focused on developing treatment strategies for pre-existing drugs that exploit unique combination regimens, and identifying and exploiting anticancer compounds. This approach has led to a number of successful areas of research, including the use of cannabinoids in combination with irradiation as a treatment of brain cancer.
Dr. Liu obtained his Ph.D. in Medical Oncology and Clinical Pharmacology from St. Bartholomew’s Hospital, London, and was a research fellow at St. Bartholomew’s and at the Institute of Cancer Research.